Debate rages over whether FDA should use emergency powers to clear a coronavirus vaccine early

Washington Post

3 September 2020 - Speeding the process could save lives, but some say it might also make it easier for the White House to push regulators to clear an unproven vaccine before Election Day.

A fierce debate has erupted over whether the Food and Drug Administration should use its emergency authority to clear a coronavirus vaccine before it is formally approved — a move opponents warn could pose safety dangers and inflame anti-vaccination sentiment but others say could save thousands of lives by speeding protection from the virus.

Read Washington Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Regulation , Vaccine , COVID-19